In this episode, Omar Khateeb explores the Elephant Slide framework and why it is becoming an essential leadership tool in MedTech boardrooms.The discussion breaks down why disconnected operational updates often create fragmented board conversations around clinical milestones, financing, regulatory progress, commercialization, and market confidence. Omar explains how strong CEOs use strategic narrative to help investors understand what the updates actually mean before uncertainty starts filling the room.Inspired by RA Capital’s SABER framework, the conversation also explores investor psychology, fundraising readiness, commercialization strategy, market engineering, and why the best MedTech leaders connect evidence, adoption, cash runway, and long term company value into one clear story.A must-listen for founders, executives, investors, and operators navigating complex growth environments in healthcare innovation.

This podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions.

Episode Breakdown

00:00 Why Board Meetings Go Wrong

00:36 What is an Elephant Slide?

00:57 Intro + Why This Matters for CEOs

01:13 Why You Should Watch This Episode

01:14 The Origin of the Elephant Slide

02:30 Why Most Board Decks Fail

04:00 The Real Problem in Board Meetings

05:40 Why CEOs Must Control the Narrative

06:30 The Blind Men and the Elephant Story

08:10 Why Board Members Get Confused

09:25 The Fictional “Neo” MedTech Example

10:15 Why Data Alone Creates Anxiety

11:17 What Board Members Are Really Thinking

14:32 The “Bottom Line First” Framework

16:00 Why Context Matters More Than Updates

17:30 How Enrollment Delays Affect Financing

18:45 Market Engineering and Board Communication

20:00 Why FDA Clearance Isn’t Enough

21:00 The Most Important Slide in Every Board Deck

22:10 Strategy vs Operations vs Housekeeping

23:00 Why Great CEOs Control the Narrative

23:58 Final Advice for Your Next Board Meeting

24:40 Outro + Subscribe

25:18 End

Are you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠GrowMyMedtech.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to book time for a free analysis.

Subscribe to our Youtube Channel

https://www.youtube.com/@thestateofmedtech

Subscribe to our LinkedIn Newsletter

https://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/

Follow The State of MedTech on

LinkedIn https://www.linkedin.com/company/thestateofmedtech/

Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/stateofmedtech/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

TikTok ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@stateofmedtechpod

X https://x.com/stateofmedtech

Facebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/stateofmedtech

Follow Omar M. Khateeb on

LinkedIn ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/in/okhateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/omar.m.khateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

TikTok https://www.tiktok.com/@omar.m.khateeb

X ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https: https://x.com/OmarMKhateeb

Facebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/OmarMKhateeb

#boardmeetings #medtech #startupleadership #venturecapital #healthcareinnovation

In this episode, Omar Khateeb speaks with Deborah K. and Virginia Giddings of Edwards Lifesciences about the future of MedTech innovation, venture capital, and strategic investment.

The conversation explores why great technology and clinical superiority alone rarely create adoption in MedTech. Topics include startup failure rates, acquisition pathways, AI-enabled robotics, minimally invasive therapies, strategic partnerships, healthcare platforms, and the system-level barriers shaping modern healthcare innovation.A sharp discussion for founders, investors, operators, and MedTech leaders building technologies that must scale beyond the product itself.

This podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions.

Episode Breakdown

00:00 Why Most MedTech Startups Fail

00:14 The Long Path of MedTech Innovation

01:01 Intro + Virginia Giddings and Deb Kilpatrick

02:14 VP of Exploration at Edwards Explained

03:26 Sonder Capital’s Investment Thesis

05:10 Why Transformational Healthcare Matters

06:12 Why Industry Leadership Matters

07:44 Healthcare is Personal for Everyone

09:09 Venture Capital vs Strategic Investors

10:32 Why MedTech Needs a Symbiotic Ecosystem

12:21 Why MedTech is Worth the Risk

13:34 Organic vs Inorganic Innovation

15:40 Why FDA Clearance Isn’t Enough

18:55 Robotics, AI, and the Future of Investing

26:44 Why MedTech Still Struggles to Attract Capital

28:33 Product Superiority vs Clinical Superiority

30:34 Why MedTech is Harder Than SaaS

31:05 AI is Reshaping Healthcare

33:14 Why Great Devices Still Fail Adoption

37:56 AI Native Companies vs AI Features

38:53 AI, Robotics, and Human Performance

40:30 AI Safety Loops in Therapeutics

41:12 AI Imaging and Automated Diagnosis

43:22 Consumer Health Data Platforms Explained

45:00 Why MedTech Needs Bigger Bets

46:49 BCI, Consumer Health, and Future Platforms

48:17 Why Healthcare Innovation Needs Systems

50:05 Consumers Are Taking Control of Healthcare

52:55 Cash Pay Healthcare and Insurance Friction

54:04 The Medicare Demographic Shift

58:41 Healthcare Savings and Consumer Empowerment

59:20 One Policy Change That Could Transform Healthcare

01:00:50 Maternal Health and Early Intervention

01:03:02 Rethinking Medicare for the Future

01:06:10 Final Thoughts on Innovation and Healthcare

01:18:00 Outro

Are you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠GrowMyMedtech.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to book time for a free analysis.

Subscribe to our Youtube Channel

https://www.youtube.com/@thestateofmedtech

Subscribe to our LinkedIn Newsletter

https://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/

Follow The State of MedTech on

LinkedIn https://www.linkedin.com/company/thestateofmedtech/

Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/stateofmedtech/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

TikTok ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@stateofmedtechpod

X https://x.com/stateofmedtech

Facebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/stateofmedtech

Follow Omar M. Khateeb on

LinkedIn ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/in/okhateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/omar.m.khateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

TikTok https://www.tiktok.com/@omar.m.khateeb

X ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https: https://x.com/OmarMKhateeb

Facebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/OmarMKhateeb

#medtech #healthcareinnovation #artificialintelligence #digitalhealth #venturecapital

In this solo episode, Omar Khateeb explores the psychology of winning companies through the lens of barbarians, bureaucrats, and hardball strategy.The episode connects lessons from Rome, Alexander the Great, Ray Kroc, Steve Jobs, Elon Musk, Intuitive, and MedTech startups to explain why speed, urgency, and conviction often beat comfort and process. Omar also breaks down why barbarian energy is powerful early, why it must evolve as companies scale, and how organizations can preserve competitive intensity without falling into chaos.

Books referenced in this episode include Hardball by George Stalk and Barbarians to Bureaucrats by Lawrence M. Miller, two frameworks that heavily shaped the conversation around competitive intensity, organizational decay, and market conquest.

This podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions.

Episode Breakdown:

00:00 Why Great Companies Become Weak

01:12 Intro + Barbarian Leadership Explained

03:20 Crossing the Chasm and Corporate Lifecycles

05:45 Founder Mode vs Bureaucracy

08:00 What is a Barbarian in Business?

10:00 Why Startups Beat Large Corporations

12:10 Prophet vs Barbarian Leadership Styles

14:30 Intuitive Surgical and MedTech Conquest

16:50 Why the Market Rewards Aggression

18:45 Steve Jobs and the Reality Distortion Field

21:00 Why Bureaucracy Kills Innovation

23:20 IBM, Comfort, and Corporate Decline

25:00 Barbarian Traits: Speed, Urgency, Conviction

27:10 Why Simplicity Beats Complexity

29:00 Rome vs Attila the Hun

31:45 Why Civilizations Collapse Internally First

34:00 Alexander the Great and Organizational Power

36:40 Elon Musk and Barbarian Leadership

39:00 Why Speed is a Competitive Weapon

41:15 Hardball Strategy Explained

43:00 Principle 1: Overwhelming Competitive Force

45:00 Principle 2: Exploit Competitor Weakness

47:00 Principle 3: Take Innovation and Scale It

49:00 Principle 4: Force Competitors to Retreat

50:50 Principle 5: Break Industry Assumptions

52:30 Why Founders Struggle to Scale Companies

54:20 Barbarian Energy vs Organizational Systems

55:40 Why Competitive Advantage Never Lasts

56:50 How Companies Lose Their Hunger

57:35 Final Thoughts on Leadership and Competition

58:40 Outro

Are you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠GrowMyMedtech.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to book time for a free analysis.

Subscribe to our Youtube Channel

https://www.youtube.com/@thestateofmedtech

Subscribe to our LinkedIn Newsletter

https://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/

Follow The State of MedTech on

LinkedIn https://www.linkedin.com/company/thestateofmedtech/

Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/stateofmedtech/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

TikTok ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@stateofmedtechpod

X https://x.com/stateofmedtech

Facebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/stateofmedtech

Follow Omar M. Khateeb on

LinkedIn ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/in/okhateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/omar.m.khateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

TikTok https://www.tiktok.com/@omar.m.khateeb

X ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https: https://x.com/OmarMKhateeb

Facebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/OmarMKhateeb

#medtech #leadership #startupstrategy #foundermode #businessgrowth #elonmusk #tesla #apple

In this episode, Omar Khateeb speaks with Chris Darland, President & CEO of Peerbridge Health, about the future of AI driven cardiac intelligence and preventive heart care. Peerbridge Health is building a platform designed to move cardiology from reactive intervention toward earlier detection through wearable ECG technology, software intelligence, and high fidelity cardiac data.Chris explains how most monitoring systems today focus mainly on arrhythmia detection, while Peerbridge is building toward a broader intelligence layer capable of identifying myocardial stress, structural defects, sleep related issues, and cardiac deterioration much earlier. The discussion also explores AI defensibility in MedTech, why proprietary data matters, how health systems could use intelligent triage tools to route patients faster, and why the future of cardiology may depend on scalable preventive infrastructure.

This podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions.

Episode Breakdown

00:00 Why Cardiac Care is Still Reactive

00:53 Intro + Chris Darland and Peerbridge Health

02:00 Growing Up Around Heart Disease

04:30 From GE to MedTech Startup CEO

05:20 The Real Problem in Cardiology Today

06:49 Scaling Cardiac Care Beyond Hospitals

08:00 Heart Failure and Readmission Crisis

09:00 Arrhythmia Monitoring Explained

10:00 Beyond Arrhythmias: Structural Heart Detection

12:00 AI + ECG for Earlier Detection

13:58 Why Most MedTech Startups Fail After FDA

14:05 Cardiac Intelligence Platform Explained

16:00 Using ECG Data to Detect Heart Disease Early

18:00 Why Signal Fidelity Matters

19:30 AI Layer for Personalized Cardiac Insights

23:00 Why Hardware + Unique Data Matter

24:08 Regulatory Strategy and FDA Pathway

27:30 NASA Signal Processing and SpaceTech Crossover

29:15 Strategic Partnerships and Acquisition Potential

31:00 Detecting Patients Before Critical Events

33:35 AI Triage for Primary Care and Cardiology

36:00 Reducing Unnecessary Specialist Visits

37:39 Using AI to Route Patients to the Right Hospital

39:00 Fundraising and Strategic Investors

41:00 Clinical Trials and Real-World Evidence

43:14 Early Trial Results and Heart Failure Detection

44:09 The Future of AI-Powered Cardiac Care

45:25 Why Mission Matters More Than Exit Price

47:40 Outro

Are you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠GrowMyMedtech.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to book time for a free analysis.

Subscribe to our Youtube Channel

https://www.youtube.com/@thestateofmedtech

Subscribe to our LinkedIn Newsletter

https://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/

Follow The State of MedTech on

LinkedIn https://www.linkedin.com/company/thestateofmedtech/

Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/stateofmedtech/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

TikTok ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@stateofmedtechpod

X https://x.com/stateofmedtech

Facebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/stateofmedtech

Follow Omar M. Khateeb on

LinkedIn ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/in/okhateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/omar.m.khateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

TikTok https://www.tiktok.com/@omar.m.khateeb

X ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https: https://x.com/OmarMKhateeb

Facebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/OmarMKhateeb

#cardiology #medtech #aiinhealthcare #digitalhealth #healthcareinnovation

In this episode, Omar Khateeb explores the hidden infrastructure behind AI, media, and markets: attention.The discussion traces how Google organized attention through PageRank, how social media platforms monetized it through engagement systems, and how AI models now operationalize it through transformer architectures built around attention mechanisms. Omar also dives into the psychology of focus, the economics of outrage, and why modern algorithms reward visibility over truth. From Elon Musk’s first-principles focus to market engineering and narrative design, the episode connects attention to everything from founder execution to cultural influence.At its core, this is a conversation about leverage.Where attention goes, energy flows and markets follow.

This podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions.

Episode Breakdown

00:00 Attention is the Foundation of AI and Modern Life

01:15 Intro + Why Attention Matters

03:00 Attention Shapes Reality

05:17 The Brain’s Spotlight Effect

07:20 Depression, Love, and Attention Patterns

08:45 The Magnifying Glass Analogy

10:05 Why Focus Creates Extraordinary Results

11:00 Elon Musk, Bottlenecks, and Concentrated Attention

14:28 Your Life Reflects What You Feed Attention To

15:00 Chamath Palihapitiya’s Attention Theory

16:05 How Google Organized Human Attention

18:00 Social Media Monetized Attention

19:30 Why Algorithms Reward Outrage and Fear

21:00 “Attention Is All You Need” Explained

22:10 How AI Uses Attention Mechanisms

23:00 AI, Transformers, and Machine Attention

23:46 Attention vs Truth

25:20 Why Society Focuses on the Wrong Problems

27:00 The Psychology of Polarization and Virality

28:30 Why Young People Want to Become Influencers

29:46 Attention, Outcomes, and the Process

31:00 Why Great Founders Focus on Process

32:15 Flow States and Deep Work

33:35 Parenting, Presence, and Attention

34:30 Marketing is About Directing Attention

35:30 Perception, Meaning, and Repetition

37:00 Why Repetition Creates Belief

39:00 Attention Engineering in Marketing

40:15 Why Most Marketing Fails

41:00 Audit Your Attention This Week

42:50 Final Thoughts on AI, Attention, and Reality

44:03 Outro

Are you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠GrowMyMedtech.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to book time for a free analysis.

Subscribe to our Youtube Channel

https://www.youtube.com/@thestateofmedtech

Subscribe to our LinkedIn Newsletter

https://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/

Follow The State of MedTech on

LinkedIn https://www.linkedin.com/company/thestateofmedtech/

Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/stateofmedtech/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

TikTok ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@stateofmedtechpod

X https://x.com/stateofmedtech

Facebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/stateofmedtech

Follow Omar M. Khateeb on

LinkedIn ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/in/okhateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/omar.m.khateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

TikTok https://www.tiktok.com/@omar.m.khateeb

X ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https: https://x.com/OmarMKhateeb

Facebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/OmarMKhateeb

#artificialintelligence #attentioneconomy #marketingpsychology #personalgrowth #futureofa

In this episode, Omar Khateeb sits down with Fazila Seker, CEO and Board Director of Insight Medbotics, to explore how meaningful MedTech innovation starts by solving real clinical problems.

Fazila shares how her team uncovered a major gap in prostate cancer care by closely observing how physicians use MRI today. That insight led to the development of an MRI-native platform designed to unify diagnosis and treatment into one precise workflow.

The conversation covers the limitations of fusion-based systems, the value of exact spatial data, and how a connected data layer can improve targeting, outcomes, and future AI-driven insights.

A sharp look at how market-driven thinking turns clinical needs into real innovation.

This podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions.

Episode Breakdown:

00:00 Why MRI Could Transform Prostate Cancer Care

01:08 Intro + Fazila Seker Background

01:54 From PhD Chemist to MedTech Founder

03:41 Why Healthcare Innovation Matters More

04:53 Why MedTech is Harder Than Tech Startups

06:14 Fall in Love With the Customer, Not the Technology

07:10 Why Physicians Resist New Technology

07:57 Building Molli Surgical Through Market Validation

09:18 Molli Surgical Explained

11:23 Getting Acquired Before FDA Clearance

13:58 Why Most MedTech Startups Fail After FDA

15:52 Market Engineering vs Traditional Go-To-Market

17:27 Why Market Pull Matters in MedTech

18:28 Inside Insight Medbotics

20:39 Why MRI Native Robotics Matters

22:57 MRI Limitations in Prostate Cancer Today

23:33 Product-Market Fit vs Market-Product Fit

24:40 Physician “Hacks” Reveal Market Opportunities

32:22 Why Fusion Imaging Falls Short

33:43 FDA Challenges of MRI Robotics

34:22 Diagnosis + Treatment in One Platform

35:25 Building a Closed-Loop MRI Data Platform

36:29 The Future AI Layer for Predictive Care

37:56 GPS for Prostate Cancer Explained

40:22 Strategic Partners: Intuitive, J&J, Medtronic

42:40 Future of Drug Delivery and Precision Oncology

44:10 Transformative Innovation vs Incremental MedTech

45:49 Why Healthcare Rewards Incremental Innovation

50:14 Why Startups Fail Without Market Need

51:20 The Problem With “Me Too” MedTech Companies

53:25 Why Transformational Thinking Wins

54:13 Fundraising, AUA, and What’s Next for Insight

55:50 Outro

Are you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠GrowMyMedtech.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to book time for a free analysis.

Subscribe to our Youtube Channel

https://www.youtube.com/@thestateofmedtech

Subscribe to our LinkedIn Newsletter

https://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/

Follow The State of MedTech on

LinkedIn https://www.linkedin.com/company/thestateofmedtech/

Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/stateofmedtech/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

TikTok ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@stateofmedtechpod

X https://x.com/stateofmedtech

Facebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/stateofmedtech

Follow Omar M. Khateeb on

LinkedIn ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/in/okhateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/omar.m.khateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

TikTok https://www.tiktok.com/@omar.m.khateeb

X ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https: https://x.com/OmarMKhateeb

Facebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/OmarMKhateeb

#medtech #prostatecancer #medicalimaging #healthcareinnovation #surgicalrobotics 

In this episode of This Month in MedTech 2026, April brings a sharper look at where the market is heading.The discussion covers Medtronic’s $100M investment in Pulnovo, why denervation may be turning into a platform strategy, and how China market access could become a bigger part of global MedTech dealmaking. The episode also unpacks Q1 funding trends, cardiovascular M&A, and key deals across thrombectomy, oncology, metabolic disease, lung cancer, and wearable robotics. The bigger message is clear: capital is still moving, but it is becoming more strategic.

This podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions.

Episode Breakdown:

00:00 Q1 2026 MedTech Funding Drops Explained

00:55 Intro + This Month in MedTech

02:13 Q1 2026 Funding Recap

04:14 Why Capital Deployment Slowed Down

06:10 Mega Rounds Decline Explained

06:58 Early Stage MedTech Funding Still Stable

07:46 MarketCraft Ad: Engineering Market Pull

11:01 LSI Alumni and Early Stage Funding Trends

12:01 Cardiovascular M&A Momentum

13:22 Stryker’s Surprise Cardiovascular Strategy

15:48 Endovascular Robotics and Platform Wars

18:36 IVL Market Growth + Strategic Acquisitions

19:59 Medtronic’s $100M Bet on Pulnovo

21:00 Why Medtronic is Suddenly Aggressive

22:11 Boston Scientific vs Medtronic Strategy

24:33 Future of Early Stage MedTech Investing

25:54 AI in MedTech Companies

27:17 Pulnovo Technology Explained

28:38 China Market Access Strategy

30:38 Platform Strategy in MedTech

32:46 Deals and Dollars Speed Round

33:21 Cala Health $50M Growth Round

34:03 Calyxo $40M Series F Explained

35:25 Endovascular Engineering $80M Series C

39:20 Sonera Therapeutics Series A

40:27 Endogenex and Metabolic Device Innovation

43:02 GLP-1 Drugs vs Device-Based Therapies

44:25 Hepa Medical Lung Cancer Technology

45:21 Wearable Robotics and Exoskeleton Market

47:34 Biggest Takeaways from April 2026

48:49 Why Platform Companies Are Winning

49:40 Free Trial for Compass AI

51:07 Final Thoughts + Outro

Are you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠GrowMyMedtech.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to book time for a free analysis.

Subscribe to our Youtube Channel

https://www.youtube.com/@thestateofmedtech

Subscribe to our LinkedIn Newsletter

https://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/

Follow The State of MedTech on

LinkedIn https://www.linkedin.com/company/thestateofmedtech/

Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/stateofmedtech/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

TikTok ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@stateofmedtechpod

X https://x.com/stateofmedtech

Facebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/stateofmedtech

Follow Omar M. Khateeb on

LinkedIn ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/in/okhateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/omar.m.khateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

TikTok https://www.tiktok.com/@omar.m.khateeb

X ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https: https://x.com/OmarMKhateeb

Facebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/OmarMKhateeb

#MedTech #HealthcareInnovation #MedicalDevices #VentureCapital #DigitalHealth

In this episode, Omar Khateeb speaks with Nick Damiano, CEO and Co-Founder of Andromeda Surgical, about how autonomous surgery could redefine surgical robotics.Nick shares how Andromeda is approaching the market differently by focusing on software, autonomy, and real-world surgical data rather than building another traditional robotics platform. The discussion covers their first beachhead in urology, why HoLEP is a powerful starting point, and how better automation could close the gap between novice and expert surgeons.They also explore founder mode in MedTech, why software scales differently than hardware, and how AI-driven robotics could create a new era of surgery for patients, surgeons, and hospitals.

This podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions

Episode Breakdown:

00:00 Autonomous Surgery Vision and Why It Matters

01:08 Intro + Nick Damiano and Andromeda Surgical

02:19 Founder Background and Journey into MedTech

04:32 Why Build Autonomous Surgical Robotics

06:20 Identifying the Right Beachhead Market (Urology)

08:27 Why Not Compete with Existing Surgical Robots

10:13 Why Most MedTech Startups Fail (Market Problem) 

13:27 Inside “Beacon” Platform: Software-First Approach

15:31 How the System Works in Real Procedures

17:08 Why Software is the Real Advantage (Not Hardware)

18:48 TechMed vs MedTech: Choosing the Right Strategy

20:39 Software Scale vs Hardware Limits Explained

22:20 Why Incumbents Will Struggle to Adapt

23:43 Hiring Philosophy: Mindset Over Experience

25:51 Why MedTech Struggles to Attract Top Talent

28:18 Founder Mode vs Traditional CEO Model

30:27 Why Founder-Led Companies Win

32:16 Hiring for Slope vs Skillset Explained

33:05 Building High-Performance Teams

36:21 Clinical Progress + Commercialization Strategy

38:35 Why Utilization Matters More Than Revenue

40:50 Redefining Surgical Robotics Category

43:12 Why Autonomy Will Transform Healthcare

45:42 How the AI System is Trained (Data + Feedback)

47:32 Future of Surgery: Outcomes, Access, Scale

49:55 Where to Find Andromeda + Closing Thoughts

51:00 Outro

Are you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠GrowMyMedtech.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to book time for a free analysis.Subscribe to our Youtube Channelhttps://www.youtube.com/@thestateofmedtechSubscribe to our LinkedIn Newsletterhttps://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/Follow The State of MedTech onLinkedIn https://www.linkedin.com/company/thestateofmedtech/Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/stateofmedtech/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@stateofmedtechpodX https://x.com/stateofmedtechFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/stateofmedtechFollow Omar M. Khateeb onLinkedIn ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/in/okhateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/omar.m.khateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok https://www.tiktok.com/@omar.m.khateebX ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https: https://x.com/OmarMKhateebFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/OmarMKhateeb⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

#medtech #surgicalrobotics #aiinhealthcare #healthcareinnovation #digitalhealth

In this episode, Omar Khateeb, Founder of Marketcraft, shares a focused breakdown of how MedTech companies build toward strong exits. Based on $17B in acquisition insights, this solo episode reframes exits as outcomes of deliberate strategy, not last-minute negotiations. Omar highlights how founders create leverage through early acquirer relationships, clear category positioning, and sustained market presence. He also explains why competitive tension matters, how timing impacts value, and why clinical clarity plays a central role in decision-making. If you want a sharper understanding of how MedTech exits actually happen, this episode gives you a clear and actionable perspective.

This podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions.

Episode Breakdown:

00:00 Why Most MedTech Exits Fail (No One Finds You)

00:59 Intro + $17B in Exit Lessons Explained

02:30 Lesson 1: Acquirer Relationships Take Years

05:30 Why Visibility and Narrative Matter

08:00 Lesson 2: The Power of Not Needing to Sell

10:30 Why 85% of Deals Have Only One Buyer 

12:44 Market Problem vs Product Problem

14:18 Strategic Investors Can Reduce Leverage

16:30 Lesson 3: Hard Endpoints vs Surrogate Metrics

19:30 Why Clinical Data Drives Acquisitions

21:53 Lesson 4: Investigators as Strategic Assets

24:30 Why Skeptics Are More Valuable Than Believers

27:00 Lesson 5: Acquirer Culture Matters More Than Price

30:00 Post-Acquisition Success vs Deal Size

31:30 Lesson 6: Phase 2 Data = Maximum Leverage

34:00 Timing Your Exit for Maximum Value

35:30 Lesson 7: CEO Resilience Drives Exit Outcomes

37:12 Final Thoughts + Founder Mindset

37:49 Outro

Are you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠GrowMyMedtech.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to book time for a free analysis.Subscribe to our Youtube Channelhttps://www.youtube.com/@thestateofmedtechSubscribe to our LinkedIn Newsletterhttps://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/Follow The State of MedTech onLinkedIn https://www.linkedin.com/company/thestateofmedtech/Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/stateofmedtech/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@stateofmedtechpodX https://x.com/stateofmedtechFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/stateofmedtechFollow Omar M. Khateeb onLinkedIn ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/in/okhateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/omar.m.khateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok https://www.tiktok.com/@omar.m.khateebX ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https: https://x.com/OmarMKhateebFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/OmarMKhateeb

#medtech #mergersandacquisitions #startupstrategy #venturecapital #healthcareinnovation 

In this episode, Omar Khateeb speaks with Dennis McWilliams, Managing Director at Santé Ventures, about what makes a medtech company investable at the early stage.From building Apollo Endosurgery to leading venture investments, Dennis shares how Santé evaluates market size, clinical risk, valuation, and exit potential. He also explains why founders should engage investors early and how disciplined capital strategy shapes outcomes.The episode highlights companies like Farapulse, Laminar, Endogenex, and Sonire Therapeutics, and the role of strategics like Medtronic, Boston Scientific, and Johnson and Johnson in driving acquisitions and growth.A focused look at how medtech capital really moves.

This podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions.

Episode Breakdown:

00:00 Harsh Truth About Startup Failure and Capital Risk

00:12 Corporate Venture vs Traditional VC

01:05 Intro + Dennis McWilliams (Sante Ventures)

02:26 Dennis Background: From Aerospace to MedTech

06:05 Why MedTech is Harder Than SaaS

08:04 Lessons from Fund IV and Market Cycles

11:51 Investment Strategy: Early Stage Focus

13:58 Why Valuation Discipline Matters 

16:31 Why Sante Stays Early Stage

18:01 Early vs Late Stage Investing Tradeoffs

21:21 Notable Wins: Cardiovascular and M&A Success

23:32 What Makes a Winning MedTech Company

23:39 Sante Investment Filter Explained

26:06 Evaluating New Markets and White Space

28:05 How VCs Find Startups

30:00 Advice for Founders Raising Capital

33:12 Minimum Requirements to Pitch a VC

35:41 Founder vs Experienced CEO Debate

39:52 When Founders Get Replaced

42:22 What VCs Look for in Founders

43:48 Corporate Venture Capital Explained

46:32 Risks and Dynamics of Corporate Investors

48:00 Founder Mistakes with Equity

48:56 Why Dilution is Misunderstood

51:51 Biggest Startup Mistakes (Valuations)

53:00 How Long VC Decisions Really Take

56:13 New Investment Spotlight (Oncology)

57:36 Rapid Fire: Learning Venture Capital

01:00:01 How Venture Really Works Behind the Scenes

01:02:00 Outro

Are you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠GrowMyMedtech.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to book time for a free analysis.Subscribe to our Youtube Channelhttps://www.youtube.com/@thestateofmedtechSubscribe to our LinkedIn Newsletterhttps://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/Follow The State of MedTech onLinkedIn https://www.linkedin.com/company/thestateofmedtech/Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/stateofmedtech/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@stateofmedtechpodX https://x.com/stateofmedtechFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/stateofmedtechFollow Omar M. Khateeb onLinkedIn ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/in/okhateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/omar.m.khateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok https://www.tiktok.com/@omar.m.khateebX ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https: https://x.com/OmarMKhateebFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/OmarMKhateeb

#medtech #venturecapital #startupfunding #healthcareinnovation #entrepreneurship